Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Helen Knight

Hundreds of blood cancer patients to benefit from new treatment

Elranatamab, an injection that treats myeloma, has been recommended for NHS use by the National Institute for Health and Care Excellence.

Evening Standard

Alzheimer’s drug rejected for widespread use by NHS spending watchdog

Donanemab is a so-called disease-modifying treatment.

Evening Standard

Patients in England to be offered daily pill that can halve migraine frequency

Nice approves first oral treatment with Atogepant that can prevent chronic and episodic migraines

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Groundbreaking migraine treatment offers ‘new hope’ for patients

‘It will especially benefit those who have not found a treatment that works’

The Independent UK

Hope for thousands as NHS approves drug for acute migraine

First and only Nice-recommended medicine could ‘alleviate misery’ of condition in England and Wales

The Guardian - UK

Migraine treatment ‘brings new hope’ for those with condition

The soluble wafer stops the release of a protein around the brain.

The Independent UK

Another weight loss jab approved for NHS use

The once-weekly jab was hailed as a ‘much-needed addition to other available treatments’

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Weight loss jab recommended to treat type 2 diabetes

The once-weekly jab was hailed as a ‘much-needed addition to other available treatments’

The Independent UK

More info needed on weight-loss jab’s impact on type 2 diabetes – Nice

The once-weekly jab would be offered to diabetic patients alongside diet and exercise,

The Independent UK

New drug could help thousands with chronic heart disease in England

Nice approves mavacamten, used to treat obstructive hypertrophic cardiomyopathy, in draft guidance to NHS

The Guardian - UK

Innovative heart condition drug recommended for NHS patients

Mavacamten would be used to treat obstructive hypertrophic cardiomyopathy, with about 7,000 people expected to benefit.

The Independent UK

Thousands of Brits with excruciating migraines to get first ever targeted drug

A first-ever dedicated oral treatment for migraines is to be offered on the NHS for more than six million people suffering from excruciating headaches after the drug Rimegepant was approved

Daily Mirror

Hero Scots dad saves elderly woman and her daughter from horror house fire

Dean Clark was on his way to work on Monday, April 24, when he saw smoke pouring into the sky from a nearby property.

Daily Record

Heroic father-of-four saves Edinburgh gran and daughter from burning inferno

Dean Clark's actions are said to have potentially saved the lives of two Niddrie family members who found themselves trapped inside a burning bungalow in the early hours of Monday morning.

Edinburgh Live

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

New breast cancer drugs to benefit thousands

Two drugs are being made available to patients through the cancer drugs fund.

Daily Mirror

Thousands of women with breast cancer could benefit from new NHS-approved pill

A clinical trial found that people taking the drug alongside hormone therapy had a more than 30% better chance of their cancer not coming back

The Guardian - UK

NHS to offer women in England drug that cuts recurrence of breast cancer

Abemaciclib can improve chances of certain type of cancer not returning after surgery by more than 30%

The Independent UK

About 4,000 women with breast cancer could benefit from new twice-daily pill

The drug, made by Eli Lilly, is suitable for those with hormone receptor-positive, HER2-negative, node-positive early breast cancer.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

New hope for women with advanced breast cancer as immunotherapy drug approved for NHS

Keytruda is for women with incurable secondary triple negative breast cancer and its aim is to slow disease progression.

The Independent UK

Women with advanced breast cancer get new immunotherapy on the NHS

Keytruda is for women with incurable secondary triple negative breast cancer and its aim is to slow disease progression.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

103 stories

the National Institute for Health and Care Excellence

12 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.